NCT00455364View on ClinicalTrials.gov

Voriconazole as Prophylactic Therapy in Lung Transplant Recipients

PHASE4TerminatedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions

Infection

Interventions

DRUG

Voriconazole

Trial Locations (1)

60637

The University of Chicago, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

University of Chicago

OTHER